¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå : ¼ºñ½º À¯Çüº°, À̹Ì¡ ¸ð´Þ¸®Æ¼º°, Ä¡·á ¿µ¿ªº°, ÀÓ»ó½ÃÇè ´Ü°èº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Imaging CRO Market, By Service Type, By Imaging Modality, By Therapeutic Area, By Clinical Trial Phase, By End User, By Geography
»óǰÄÚµå
:
1747272
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
À̹Ì¡ CRO ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 56¾ï 1,000¸¸ ´Þ·¯, 2032³â¿¡´Â 96¾ï 8,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â CAGR 8.1%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
º¸°í¼ ¹üÀ§
º¸°í¼ »ó¼¼
±âÁØ ¿¬µµ
2024
2025³â ½ÃÀå ±Ô¸ð
56¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR
8.10%
2032³â °¡Ä¡ ¿¹Ãø
96¾ï 8,000¸¸ ´Þ·¯
¼¼°è À̹Ì¡ CRO ½ÃÀåÀº ÇコÄÉ¾î »ê¾÷¿¡¼ Áß¿äÇÑ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ÀÇ·á À̹Ì¡ ±â¼ú °³¹ß ¹× °³Ã´¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À̹Ì¡ CRO(Contract Research Organizations)´Â ÀÓ»ó½ÃÇè ¹× Á¶»ç ¿¬±¸¸¦ Áö¿øÇϱâ À§ÇØ ¿µ»ó Áø´Ü ÇÁ·ÎÅäÄÝ ¼³°è, À̹ÌÁö ¼öÁý, ºÐ¼® ¹× ÆÇµ¶À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇÏ´Â °ÍÀ» Àü¹®À¸·Î ÇÕ´Ï´Ù. À̵é Á¶Á÷Àº ÃÖ÷´Ü ±â¼ú°ú Àü¹® Áö½ÄÀ» Ȱ¿ëÇÏ¿© Á¦¾àȸ»ç¿Í »ý¸í°øÇÐ ±â¾÷ÀÌ ÀǾàǰ °³¹ß °úÁ¤¿¡¼ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï °íǰÁúÀÇ ¿µ»ó µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯ Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ °³¹ßÀÇ Çʿ伺ÀÌ ¼¼°è À̹Ì¡ CRO ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÇコÄɾî ȯ°æÀÌ °è¼Ó ÁøÈÇÔ¿¡ µû¶ó Çõ½ÅÀûÀÎ Ä¡·á¹ý °³¹ßÀ» °¡¼ÓÈÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ÀÖ¾î À̹Ì¡ CROÀÇ ¿ªÇÒÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è À̹Ì¡ CRO ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ È®»ê, ÷´Ü À̹Ì¡ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ °³¹ß ÇÁ·Î¼¼½º¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡ µî ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È·Î ÀÎÇØ ¾Ï, ½ÉÇ÷°ü Áúȯ, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ÷´Ü ¿µ»ó ±â¼úÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ÃâÇöÀ¸·Î Ç¥Àû Ä¡·áÀÇ °³¹ßÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú°í, ȯÀÚ ¼±Åðú Ä¡·á ¹ÝÀÀ¼º Æò°¡¸¦ À§ÇØ ¿µ»ó ¹ÙÀÌ¿À¸¶Ä¿¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿µ»ó ÀåºñÀÇ ³ôÀº ºñ¿ë, º¹ÀâÇÑ ±ÔÁ¦ ¿ä°Ç, ÀÌ ºÐ¾ßÀÇ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ, À̹Ì¡ ÇÁ·ÎÅäÄݰú µ¥ÀÌÅÍ °ü¸®ÀÇ Ç¥ÁØÈ ºÎÁ·Àº À̹Ì¡ CRO°¡ ¼·Î ´Ù¸¥ ½Ã¼³°ú ¿¬±¸ °£¿¡ À̹Ì¡ µ¥ÀÌÅÍÀÇ ½Å·Ú¼º°ú ÀçÇö¼ºÀ» º¸ÀåÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ÀΰøÁö´É, ¸Ó½Å·¯´×, Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ µî ¿µ»óÁø´ÜÀÇ Àü¸ÁÀ» ¹Ù²Ù°í ÀÖ´Â ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº º¸´Ù ºü¸£°í Á¤È®ÇÑ ¿µ»ó ºÐ¼®À» °¡´ÉÇÏ°Ô Çϰí, µ¥ÀÌÅÍ °ü¸®¸¦ °£¼ÒÈÇϸç, ÀÌÇØ°ü°èÀÚ°£ÀÇ ¿ø°Ý Çù¾÷À» ÃËÁøÇÕ´Ï´Ù. ¶ÇÇÑ PET/CT ¹× PET/MRI¿Í °°Àº ÇÏÀ̺긮µå À̹Ì¡ ¾ç½ÄÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸ÖƼ¸ð´Þ À̹Ì¡ ¿¬±¸¸¦ Áö¿øÇÏ´Â À̹Ì¡ CROÀÇ ¹üÀ§°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è À̹Ì¡ CRO ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
À̹Ì¡ CRO ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è À̹Ì¡ CRO ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å/½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
¾÷°è µ¿Çâ
Á¦4Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, ¼ºñ½º À¯Çüº°, 2020³â-2032³â
ÀÓ»ó½ÃÇè À̹Ì¡
ÀüÀÓ»ó À̹Ì¡
ÀÇ·á ¿µ»ó µ¥ÀÌÅÍ °ü¸®
¿µ»ó ó¸® ¹× ºÐ¼® ¼ºñ½º
±ÔÁ¦ ÄÁ¼³ÆÃ
±âŸ(ǰÁú°ü¸® µî)
Á¦5Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, À̹Ì¡ ¸ð´Þ¸®Æ¼º°, 2020³â-2032³â
Àڱ⠰ø¸í ¿µ»ó(MRI)
ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT)
¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ(PET)
ÃÊÀ½ÆÄ
X¼±
±¤ÇÐ À̹Ì¡
Á¦6Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, Ä¡·á ¿µ¿ªº°, 2020³â-2032³â
Á¾¾çÇÐ
½Å°æÇÐ
½ÉÀ庴ÇÐ
±Ù°ñ°Ý°è Àå¾Ö
¼Òȱ⳻°ú
³»ºÐºñÇÐ
±âŸ
Á¦7Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, ÀÓ»ó½ÃÇè ´Ü°èº°, 2020³â-2032³â
´Ü°è I
´Ü°è II
´Ü°è III
´Ü°è IV
Á¦8Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â
Á¦¾àȸ»ç
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
ÀÇ·á±â±â Á¦Á¶¾÷ü
Áø´Ü¼¾ÅÍ
¼öŹ¿¬±¸±â°ü
Çмú¿¬±¸±â°ü
Á¦9Àå ¼¼°èÀÇ À̹Ì¡ CRO ½ÃÀå, Áö¿ªº°, 2020³â-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¶ÀÏ
¿µ±¹
½ºÆäÀÎ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
È£ÁÖ
Çѱ¹
ASEAN
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
秵GCC ±¹°¡
À̽º¶ó¿¤
±âŸ Áßµ¿
¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
ºÏ¾ÆÇÁ¸®Ä«
Áß¾Ó¾ÆÇÁ¸®Ä«
Á¦10Àå °æÀï ±¸µµ
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Agfa-Gevaert Group
Hitachi Medical Corporation
Carestream Health
Hologic, Inc.
Toshiba Medical Systems
Mindray Medical International Limited
Varian Medical Systems
Esaote S.p.A.
Bracco Imaging S.p.A.
Leica Biosystems
Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×
±âȸ
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map
Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í ¹®Çå
Á¶»ç ¹æ¹ý
ÃâÆÇ»ç¿¡ ´ëÇØ
LSH
¿µ¹® ¸ñÂ÷
Global Imaging CRO Market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 5.61 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
8.10%
2032 Value Projection:
USD 9.68 Bn
The global imaging CRO market has emerged as a crucial sector within the healthcare industry, playing a pivotal role in the development and advancement of medical imaging technologies. Imaging Contract Research Organizations (CROs) specialize in providing a wide range of services, including imaging protocol design, image acquisition, analysis, and interpretation, to support clinical trials and research studies. These organizations leverage cutting-edge technologies and expertise to deliver high-quality imaging data, enabling pharmaceutical and biotechnology companies to make informed decisions during the drug development process. The increasing prevalence of chronic diseases, coupled with the growing demand for personalized medicine and the need for efficient and cost-effective drug development, has fueled the growth of the global imaging CRO market. As the healthcare landscape continues to evolve, the role of imaging CROs is becoming increasingly important in accelerating the development of innovative therapies and improving patient outcomes.
Market Dynamics
The global imaging CRO market growth is driven by several key factors, including the increasing prevalence of chronic diseases, rising demand for advanced imaging technologies, and the growing need for efficient and cost-effective drug development processes. The aging population and changing lifestyles have led to a higher incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which require advanced imaging techniques for diagnosis and monitoring. Additionally, the advent of personalized medicine has necessitated the development of targeted therapies, which rely heavily on imaging biomarkers for patient selection and treatment response assessment. However, the market growth may be restrained by factors such as the high cost of imaging equipment, complex regulatory requirements, and the shortage of skilled professionals in the field.
Furthermore, the lack of standardization in imaging protocols and data management poses challenges for imaging CROs in ensuring the reliability and reproducibility of imaging data across different sites and studies. Despite these challenges, the market presents significant opportunities for growth, driven by technological advancements such as artificial intelligence, machine learning, and cloud computing, which are transforming the imaging landscape. These technologies enable faster and more accurate image analysis, streamline data management, and facilitate remote collaboration among stakeholders. Moreover, the increasing adoption of hybrid imaging modalities, such as PET/CT and PET/MRI, is expected to expand the scope of Imaging CROs in supporting multimodal imaging studies.
Key Features of the Study
This report provides in-depth analysis of the global imaging CRO market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Imaging CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Hitachi Medical Corporation, Carestream Health, Hologic, Inc., Toshiba Medical Systems, Mindray Medical International Limited, Varian Medical Systems, Esaote S.p.A., Bracco Imaging S.p.A., and Leica Biosystems
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global imaging CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global imaging CRO market
Market Segmentation
Service Type Insights (Revenue, USD Bn, 2020 - 2032)
Clinical Trial Imaging
Preclinical Imaging
Medical Imaging Data Management
Image Processing & Analysis Services
Regulatory Consultancy
Others (Quality Control, etc.)
Imaging Modality Insights (Revenue, USD Bn, 2020 - 2032)
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Ultrasound
X-ray
Optical Imaging
Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
Oncology
Neurology
Cardiology
Musculoskeletal Disorders
Gastroenterology
Endocrinology
Others
Clinical Trial Phase Insights (Revenue, USD Bn, 2020 - 2032)
Phase I
Phase II
Phase III
Phase IV
End User Insights (Revenue, USD Bn, 2020 - 2032)
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Diagnostic Centers
Contract Research Organizations
Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Agfa-Gevaert Group
Hitachi Medical Corporation
Carestream Health
Hologic, Inc.
Toshiba Medical Systems
Mindray Medical International Limited
Varian Medical Systems
Esaote S.p.A.
Bracco Imaging S.p.A.
Leica Biosystems
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Imaging CRO Market, By Service Type
Global Imaging CRO Market, By Imaging Modality
Global Imaging CRO Market, By Therapeutic Area
Global Imaging CRO Market, By Clinical Trial Phase
Global Imaging CRO Market, By End User
Global Imaging CRO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Imaging CRO Market, By Service Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Clinical Trial Imaging
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Preclinical Imaging
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Imaging Data Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Image Processing & Analysis Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Regulatory Consultancy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Quality Control, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Imaging CRO Market, By Imaging Modality, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Magnetic Resonance Imaging (MRI)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Computed Tomography (CT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Positron Emission Tomography (PET)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ultrasound
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
X-ray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Optical Imaging
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Imaging CRO Market, By Therapeutic Area, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Musculoskeletal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastroenterology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Imaging CRO Market, By Clinical Trial Phase, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Phase I
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Phase II
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Phase III
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Phase IV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Imaging CRO Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Manufacturers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Imaging CRO Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Siemens Healthineers
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GE Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Philips Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Canon Medical Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fujifilm Holdings Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Agfa-Gevaert Group
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hitachi Medical Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Carestream Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hologic, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Toshiba Medical Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mindray Medical International Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Varian Medical Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Esaote S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bracco Imaging S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Leica Biosystems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
°ü·ÃÀÚ·á